Koers Tiziana Life London S.E.
Aandelen
TILS
GB00BKWNZY55
Biotechnologie & Medisch Onderzoek
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 60,66 mln. 56,74 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -23 mln. -21,51 mln. | Nettowinst (verlies) 2022 | -15 mln. -14,03 mln. | EV/omzet 2021 | - |
Nettoliquiditeiten 2021 | 42,19 mln. 39,45 mln. | Nettoliquiditeiten 2022 | 17,76 mln. 16,61 mln. | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-4,01
x | K/w-verhouding 2022 |
-3,95
x | Werknemers | 9 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 32,56% |
Recentste transcriptie over Tiziana Life
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11-02-98 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 01-07-20 |
Willy Simon
BRD | Director/Board Member | 72 | 01-11-15 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11-02-98 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |